Semaglutide
unknown
Verified
Chemical Information
Clinical Information
Dosing:
Subcutaneous injection, oral
Safety Information
Side Effects:
- Nausea, vomiting, diarrhea, abdominal pain
Research & References
- Lau J, et al. (2015) Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem, 58(18), 7370-7380.
Last updated: 3/28/2025 at 6:59:56 AM
Version: 1
Detailed Information
Primary Uses
Last updated: March 28, 2025
Version: 1